Anand Ravindran GlaxoSmithKline
1 protocol

HongLok Lung University of Hong Kong
61 protocols

Tim Smith University of Aberdeen
4 protocols

Vanesa Olivares-Illana Instituto de Física, Universidad Autónoma de San Luis Potosí
15 protocols

Reviewer
Shyam Srivats
  • Research scientist, University of California, San Francisco
Research focus
  • Cancer biology
  • Cancer biology, cell biology, immunology, cell therapy
3 Protocols reviewed
A Potent Vaccine Delivery System
Authors:  Guangzu Zhao, Armira Azuar, Istvan Toth and Mariusz Skwarczynski, date: 04/05/2021, view: 2412, Q&A: 0

Most vaccines require co-delivery of an adjuvant in order to generate the desired immune responses. However, many currently available adjuvants are non-biodegradable, have limited efficacy, and/or poor safety profile. Thus, new adjuvants, or

...
More >
In vitro STING Activation with the cGAMP-STINGΔTM Signaling Complex
Authors:  Yanpu He, Celestine Hong, Darrell J. Irvine, Jiahe Li and Paula T. Hammond, date: 02/05/2021, view: 2165, Q&A: 0
Activating the STING (stimulator of interferon genes) signaling pathway via administration of STING agonist cyclic GMP-AMP (cGAMP) has shown great promise in cancer immunotherapy. While state-of-the-art approaches have predominantly focused on the ...
More >
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.